BioVie to discuss Phase 2 Long Covid trial results in conference call
Tweet Send to a Friend
BioVie Inc. (NASDAQ: BIVI) announced it will host a conference call and webcast on September 15, 2026, at 8:30 a.m ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
